One River Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,200
Closed -$80.2K 307
2024
Q3
$80.2K Buy
1,200
+400
+50% +$36.7K 0.01% 268
2024
Q2
$95K Buy
+800
New +$101K 0.01% 221
2024
Q1
Sell
-1,300
Closed -$129K 300
2023
Q4
$129K Sell
1,300
-4,700
-78% -$395K ﹤0.01% 265
2023
Q3
$620K Hold
6,000
0.02% 229
2023
Q2
$729K Sell
6,000
-20,200
-77% -$2.69M 0.08% 133
2023
Q1
$4.02M Buy
26,200
+22,600
+628% +$3.73M 0.18% 96
2022
Q4
$647K Buy
+3,600
New +$589K 0.04% 244

Other funds holding MRNA

One River Asset Management's MRNA Position: Q4 2024 in Review

One River Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 801 shares — an estimated $52.7K sold.

One River Asset Management first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $582K in Q2 2023. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • One River Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • One River Asset Management sold 801 Moderna shares in Q4 2024, an estimated $52.7K.
  • One River Asset Management first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • One River Asset Management's Moderna position peaked at $582K in Q2 2023.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on One River Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.